Facebook
X
LinkedIn
Forward| Title | Credit | Series date | Member price |
Non-member price |
|---|---|---|---|---|
|
2025 Psychopharmacology Update 2.75 NAPNAP Contact Hour of which 2.75 pharmacology content, 2.75 are Psychopharmacology content and 0.25 are Controlled Substance content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. Children and adolescents with behavioral health conditions are commonly seen in all pediatric environments. We will focus on the emerging use of long-acting formulations for management of chronic psychiatric conditions and other new pharmacologic approaches to behavioral health management. This presentation is solely focused on pharmacology and aims to help demystify these medications for the pediatric provider. NAPNAP’s Developmental Behavioral and Mental Health SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
PIDS: Acute Sinusitis in Pediatrics 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of sinusitis in children in ambulatory care. This module will review the key differences between upper respiratory tract infections and sinusitis. Apply this knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Urinary Tract Infections 0.25 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of pediatric urinary tract infection in ambulatory care. Learn about the diagnosis and treatment of pediatric UTI. Apply this knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Group A Streptococcal Pharyngitis 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of Group A Streptococcus. Learn about the importance of utilizing the Modified Centor Score to determine when to test for Group A Strep. Review evidence for appropriate antibiotic treatment for Group A Strep. Apply this new knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
Emerging Health Threats in Infants: Perinatal Hepatitis C 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. Emerging Health Threats in Infants: Perinatal Hepatitis C. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with NAPNAP Partners for Vulnerable Youth. This continuing education activity is offered free for NAPNAP members and nonmembers. |
|
10/06/2020 to 08/29/2027 | $0.00 | $0.00 |
|
Keeping Current in Atopic Diseases 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
PIDS: Antimicrobial Stewardship for Advanced Practice Providers 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will highlight the key concepts related to antimicrobial stewardship for Advanced Practice Providers in the outpatient environment. Learn the core strategies to combat the threat of antimicrobial resistance. Improving antibiotic use amongst all providers is a key component in reducing inappropriate antimicrobial use and antibiotic resistance. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
Emerging Health Threats in Infants: Congenital Syphilis 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. Emerging Health Threats in Infants: Congenital Syphilis |
|
04/08/2025 to 04/30/2027 | $0.00 | $0.00 |
|
New Pediatric Antibiotic Prescribing Guidelines 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Hidden in Plain Sight: Uncovering Cytomegalovirus (CMV) for the Pediatric NP 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
JPHC CE: The Landscape of Substance Use in Youth-2024 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. An essential role of pediatric providers is to counsel youth and parents on behavioral health issues, including the use of Alcohol or other drugs (AODs). Although substance use by adolescents has decreased, a significant number of adolescents use AODs, causing those with regular use to be at risk of developing behavioral, physical, and mental health consequences that can continue into adulthood. This article was written to help pediatric providers understand the scope and associated effects of AOD use in their adolescent patients and equip them to counsel, identify, and intervene to reduce the harm to their patients who use AODs. J Pediatr Health Care (2025) XX, 1-12. |
|
11/01/2025 to 12/31/2026 | $0.00 | $10.00 |
|
NP Preceptor: Telehealth Interprofessional Practice 0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $5 for NAPNAP Members. For non- members, this continuing education activity rate is $10. This module will introduce telehealth delivered by Nurse Practitioners in the context of a primary care practice. This module introduces the basic concepts of Telehealth Interprofessional Practice. The module takes approximately 30 minutes to complete and you may complete it at your own pace. Pre-Test - Please complete the pre-test. It only takes about 3 minutes. Test results are reported as AGGREGATE DATA ONLY for us to evaluate the effectiveness of each learning module. |
|
07/30/2019 to 06/30/2026 | $5.00 | $10.00 |
|
JPHC CE: Preventing HIV in the Adolescent Population with PrEP: The Role of the Nurse Practitioner 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Preexposure prophylaxis (PrEP) uptake remains low among adolescents and young adults at high risk due to various barriers, such as decreased access to care, human immunodeficiency virus (HIV) stigma, and misinformation. The barriers to the uptake of PrEP among adolescents and young adults are multifaceted and require comprehensive mitigation strategies. Presented is the epidemiology of HIV, pathophysiology, and complications of HIV in adolescents, history of PrEP research, “How to End the HIV Epidemic in the U.S.” plan, reviewing and eliminating barriers to PrEPcare, PrEP curriculum opportunities for the provider, and the role of the nurse practitioner in reducing new HIV diagnoses in adolescents. J pediatr Health Care. (2025) 39, 503−514. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
|
JPHC CE: Secondhand Smoke Exposure in Pediatric Patients: What Is the Nurse Practitioner’s Role? 0.75 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. The detrimental impact of smoking is extensively known and documented. However, what about those who cannot make that choice for themselves? Unlike most adults, children have little to no control over their environment, relying heavily on the choices and actions of their parent(s). While this is true with various factors, it is especially true with secondhand smoke exposure (SHSe). No amount of smoke is a safe level to be around, especially in infancy and childhood. The American Academy of Pediatrics (AAP) defines secondhand smoke (SHS) as “smoke emitted from a tobacco product or exhaled from a person who smokes that is inhaled by a person who does not smoke,” enveloping involuntary participants like infants and children (Jenssenetal.,2023). This continuing education paper strives to give insight into the dangers of SHSe for children, a guide for providers, and resources for parent(s) struggling with tobacco dependency. J Pediatr Health Care. (2024) 38, Issue 6, 936-942. |
|
11/01/2024 to 12/31/2025 | $0.00 | $10.00 |